tiprankstipranks
Cue Biopharma Inc (CUE)
NASDAQ:CUE
US Market

Cue Biopharma (CUE) Stock Investors

Compare
598 Followers
Based on 793,835 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CUE
On average, investors allocate 3.28% of their portfolios to CUE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 793,835 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CUE

1.5%
Last 7
Days
1.4%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CUE, out of 793,835 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CUE Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.36%
$1.69
Based on the activity of investors who made their portfolios public
The table shows changes in CUE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CUE Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
3.84%
-0.74%
-2.78%
2.93B
Healthcare
Nio
8.87%
-0.60%
-0.77%
8.67B
Consumer Cyclical
CVS Health
4.37%
-1.47%
-1.86%
85.22B
Healthcare
Lucid Group
5.42%
-0.27%
+0.23%
7.03B
Consumer Cyclical
Block
3.61%
+0.54%
+3.64%
34.28B
Technology
Marathon Digital Holdings
4.95%
-0.29%
>-0.01%
4.72B
Financial
Delta Air Lines
4.74%
+0.06%
+3.58%
28.32B
Industrials
Raytheon Technologies
3.79%
-0.33%
+3.57%
178.14B
Industrials
Spotify
5.17%
+0.23%
+2.73%
112.67B
Communication Services
Bristol-Myers Squibb
3.52%
-1.07%
-0.87%
122.13B
Healthcare
Based on the activity of 793,835 active portfolios
Open your Smart Portfolio

CUE Investor Analysis

CUE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
3.9%
of CUE holders
are under 35
Average Segment Performance
Average P/E Ratio17.86
Beta11.00
Dividend Yield3.91%
CUE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
63.1%
of CUE holders
are between 35–55
Average Segment Performance
Average P/E Ratio16.98
Beta19.48
Dividend Yield3.42%
CUE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
33.0%
of CUE holders
are over 55
Average Segment Performance
Average P/E Ratio13.92
Beta12.14
Dividend Yield3.66%
Overview of age group and performance of CUE stock investors
See who invests in CUE according to age group and performance.

FAQ

How many retail Investors hold CUE?
<0.1% of TipRanks' retail investors hold CUE in their portfolios.
    What is CUE Investor Sentiment?
    CUE’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of CUE in the last 7 days?
      ▼ 1.5% of TipRanks' retail investors changed their holding of CUE in the last 7 days.
        What percentage of retail investors changed their holding of CUE in the last 30 days?
        ▼ 1.4% of TipRanks' retail investors changed their holding of CUE in the last 30 days.
          What is the average age of retail investors who hold CUE?
          The average age of CUE Holders is between 35–55.
            What other stocks have CUE investors also bought?
            CUE Investors also bought VKTX, NIO, CVS, LCID, XYZ, MARA, DAL, RTX, SPOT, BMY.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALKSAlkermes
              ALGNAlign Tech
              CORCencora
              AZNAstraZeneca
              BIIBBiogen
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis